Literature DB >> 29481307

Histone demethylase JMJD3 regulates fibroblast-like synoviocyte-mediated proliferation and joint destruction in rheumatoid arthritis.

Wanwan Jia1,2, Weijun Wu1, Di Yang1, Chenxi Xiao1, Zhenghua Su1, Zheng Huang3, Zhongzheng Li4, Ming Qin1, Mengwei Huang1, Siyu Liu1, Fen Long1, Jianchun Mao5, Xinhua Liu1, Yi Zhun Zhu1,2.   

Abstract

Rheumatoid arthritis (RA) is an immune-mediated disease with the characteristics of progressive joint destruction, deformity, and disability. Epigenetic changes have been implicated in the development of some autoimmune disorders, resulting in an alteration of gene transcription. Here, we investigated how Jumonji C family of histone demethylases (JMJD3) regulated the proliferation and activation of fibroblast-like synoviocytes (FLSs), which are involved in RA joint destruction and pathologic process. The JMJD3 expression and proliferation markers in RA-FLS were higher than those in healthy-FLS and were upregulated in platelet-derived growth factor (PDGF)-induced FLS. Elevated JMJD3 promoted the proliferation and migration of FLS. Treatment with JMJD3 small interfering RNA or inhibitor glycogen synthase kinase (GSK) J4 led to decreased proliferation and migration of FLS. Interestingly, induction of proliferating cell nuclear antigen (PCNA), a major player of the cell-cycle regulation, was correlated with trimethylated lysine 27 in histone H3 loss around the gene promoters. The knockdown of JMJD3 abolished PCNA expression in PDGF-induced FLS and further inhibited cell proliferation and migration, suggesting that JMJD3/PCNA played a crucial role in aspects of FLS proliferation and migration. In vivo, the ability of GSK J4 to hinder collagen-induced arthritis (CIA) in DBA/1 mice was evaluated. We found that GSK J4 markedly attenuated the severity of arthritis in CIA mice. The therapeutic effects were associated with ameliorated joint swelling and reduced bone erosion and destruction. This study revealed how JMJD3 integrated with epigenetic processes to regulate RA-FLS proliferation and invasion. These data suggested that JMJD3 might contribute to rheumatoid synovial hyperplasia and have the potential as a novel therapeutic target for RA.-Jia, W., Wu, W., Yang, D., Xiao, C., Su, Z., Huang, Z., Li, Z., Qin, M., Huang, M., Liu, S., Long, F., Mao, J., Liu, X., Zhu, Y. Z. Histone demethylase JMJD3 regulates fibroblast-like synoviocyte-mediated proliferation and joint destruction in rheumatoid arthritis.

Entities:  

Keywords:  GSK J4; epigenetic alteration; platelet-derived growth factor; proliferating cell nuclear antigen

Mesh:

Substances:

Year:  2018        PMID: 29481307     DOI: 10.1096/fj.201701483R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  17 in total

1.  Cystathionine-γ-lyase ameliorates the histone demethylase JMJD3-mediated autoimmune response in rheumatoid arthritis.

Authors:  Weijun Wu; Ming Qin; Wanwan Jia; Zheng Huang; Zhongzheng Li; Di Yang; Mengwei Huang; Chenxi Xiao; Fen Long; Jianchun Mao; Philip K Moore; Xinhua Liu; Yi Zhun Zhu
Journal:  Cell Mol Immunol       Date:  2018-05-29       Impact factor: 11.530

Review 2.  Emerging roles of JMJD3 in cancer.

Authors:  Maryam Farzaneh; Zeinab Kuchaki; Fatima Rashid Sheykhahmad; Seyed Mohammadmahdi Meybodi; Yusef Abbasi; Effat Gholami; Farhoodeh Ghaedrahmati; Omid Anbiyaee
Journal:  Clin Transl Oncol       Date:  2022-03-03       Impact factor: 3.405

3.  Overexpression of Aquaporin 1 in Synovium Aggravates Rat Collagen-Induced Arthritis Through Regulating β-Catenin Signaling: An in vivo and in vitro Study.

Authors:  Yu-Rong Mu; Meng-Yuan Zhou; Li Cai; Ming-Ming Liu; Rong Li
Journal:  J Inflamm Res       Date:  2020-10-08

Review 4.  Why remission is not enough: underlying disease mechanisms in RA that prevent cure.

Authors:  Georg Schett; Yoshiya Tanaka; John D Isaacs
Journal:  Nat Rev Rheumatol       Date:  2020-12-10       Impact factor: 20.543

5.  Long non-coding RNA PVT1 knockdown suppresses fibroblast-like synoviocyte inflammation and induces apoptosis in rheumatoid arthritis through demethylation of sirt6.

Authors:  Chun-Wang Zhang; Xia Wu; Dan Liu; Wei Zhou; Wei Tan; Yu-Xuan Fang; Yu Zhang; Yan-Qing Liu; Guo-Qing Li
Journal:  J Biol Eng       Date:  2019-07-02       Impact factor: 4.355

Review 6.  JMJD3 in the regulation of human diseases.

Authors:  Xiangxian Zhang; Li Liu; Xia Yuan; Yuquan Wei; Xiawei Wei
Journal:  Protein Cell       Date:  2019-11-07       Impact factor: 14.870

7.  KDM6B is an androgen regulated gene and plays oncogenic roles by demethylating H3K27me3 at cyclin D1 promoter in prostate cancer.

Authors:  Zhi Cao; Xiaolei Shi; Feng Tian; Yu Fang; Jason Boyang Wu; Stefan Mrdenovic; Xinwen Nian; Jin Ji; Huan Xu; Chen Kong; Yalong Xu; Xi Chen; Yuhua Huang; Xuedong Wei; Yongwei Yu; Bo Yang; Leland W K Chung; Fubo Wang
Journal:  Cell Death Dis       Date:  2021-01-06       Impact factor: 8.469

Review 8.  Histone 3 Lysine 27 Trimethylation Signature in Breast Cancer.

Authors:  Lidia Borkiewicz
Journal:  Int J Mol Sci       Date:  2021-11-27       Impact factor: 5.923

9.  The Preparation of a Novel Poly(Lactic Acid)-Based Sustained H2S Releasing Microsphere for Rheumatoid Arthritis Alleviation.

Authors:  Yue Yu; Zhou Wang; Qian Ding; Xiangbin Yu; Qinyan Yang; Ran Wang; Yudong Fang; Wei Qi; Junyi Liao; Wei Hu; Yizhun Zhu
Journal:  Pharmaceutics       Date:  2021-05-18       Impact factor: 6.321

10.  Knockdown of long non-coding RNA PVT1 induces apoptosis of fibroblast-like synoviocytes through modulating miR-543-dependent SCUBE2 in rheumatoid arthritis.

Authors:  Junxia Wang; Xianghui Kong; Haijian Hu; Shunfang Shi
Journal:  J Orthop Surg Res       Date:  2020-04-15       Impact factor: 2.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.